News & Perspective

Oct 15, 2004

Oct 15, 2004

None of Chiron's flu vaccine is safe, FDA says

(CIDRAP News) – Federal health officials today ruled out using any of Chiron Corporation's influenza vaccine in the United States this year, following the completion of inspections at the company's plant in Liverpool, England.

Oct 19, 2004

Oct 19, 2004

Aventis to produce 2.6 million more flu vaccine doses

(CIDRAP News) – Seeking to calm public worries about the influenza vaccine shortage, Health and Human Services (HHS) Secretary Tommy Thompson announced today that Aventis Pasteur will produce another 2.6 million doses for distribution in January.

Oct 22, 2004

Oct 22, 2004

More nasal-spray flu vaccine on the way

(CIDRAP News) – MedImmune will produce another million doses of its nasal-spray influenza vaccine, FluMist, which could free up some injectable flu vaccine for high-risk groups, Health and Human Services (HHS) Secretary Tommy Thompson announced yesterday.

Oct 28, 2004

Oct 28, 2004

Progress on flu vaccine supply announced

(CIDRAP News) – About 5 million additional doses of injectable flu vaccine have been identified that will hopefully be added to the US supply, according to an announcement made today by Department of Health and Human Services (HHS) Secretary Tommy Thompson. In addition, 300,000 doses are being redirected to high-risk individuals from stores originally planned for military personnel and federal employees.

Dec 07, 2004

Dec 07, 2004

HHS buys 1.2 million flu vaccine doses from abroad

(CIDRAP News) – The federal government is buying 1.2 million doses of flu vaccine made in Germany to augment the strained US supply, the Department of Health and Human Services (HHS) announced today.

Jun 27, 2005

Jun 27, 2005

Momentum builds for cell-culture flu vaccines

(CIDRAP News) – You've got to gather a lot of eggs to supply the world with influenza vaccine, but that might change before long.

Oct 05, 2006

Oct 05, 2006

FDA approves 5th flu vaccine

(CIDRAP News) – FluLaval has become the fifth influenza vaccine licensed by the US Food and Drug Administration (FDA) for use during the upcoming flu season, the FDA announced today.

FluLaval, produced by ID Biomedical Corp. of Quebec, a subsidiary of GlaxoSmithKline (GSK), has been marketed in Canada under the brand name Fluviral since 2001. It was granted fast-track review status by the FDA in July 2005.

Feb 21, 2007

Feb 21, 2007

WHO picks one new strain for 2007-08 flu vaccine

Feb 20, 2007 (CIDRAP News) – Because of changes in the influenza viruses now in circulation, the World Health Organization (WHO) has recommended changing one of the three viral strains to be used in flu vaccines in the Northern Hemisphere next fall and winter.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 03, 2008

Oct 03, 2008

Plant cancellation shows problems in flu vaccine business

(CIDRAP News) – A flu vaccine manufacturer's decision not to build a US facility has highlighted the perpetual mismatch between flu-shot supply and demand—and the reality that the mismatch may undermine plans for pandemic flu vaccines.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»